Seelos Therapeutics Prices $5.55M Public Offering, Including Shares And Warrants
Portfolio Pulse from Benzinga Newsdesk
Seelos Therapeutics, Inc. (NASDAQ:SEEL) has announced the pricing of its public offering at $5.55 million, which includes 1,781,934 shares of common stock, pre-funded warrants for 2,422,612 shares, and common warrants for 4,204,546 shares. The offering price is $1.32 per share of common stock and accompanying common warrant, and $1.319 per pre-funded warrant and accompanying common warrant.
November 29, 2023 | 7:12 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Seelos Therapeutics has priced a public offering at $5.55 million, which may dilute current shareholders but also provides capital for operations and development.
Public offerings often lead to dilution of existing shares, which can result in a short-term negative impact on the stock price. However, the capital raised can be beneficial for the company's long-term growth and development.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100